No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
383 |
4. Check minimum number of eventsNone |
383 |
5. Include endpointsNone |
383 |
6. Filter based on genotype QC (FinnGen only) |
383 |
Control definitions (FinnGen only)
- Control exclude
- G6_DEMYEL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G35-G37
- Name in latin
- Alia demyelinatio disseminata acuta
Similar endpoints
↥List of similar endpoints to
Other acute disseminated demyelination
based on the number of shared cases.
Similar with more cases:
- Demyelinating diseases of the central nervous system
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2214 | 1475 | 720 |
| Only index persons | 2052 | 1408 | 644 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 38.77 | 38.00 | 40.00 |
| Only index persons | 37.80 | 37.69 | 38.05 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 383 | 288 | 95 |
| Unadjusted period prevalence (%) | 0.08 | 0.10 | 0.04 |
| Median age at first event (years) | 37.80 | 36.62 | 41.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 341
- Matched controls
- 3410
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
286.5
233
*
G35
ICD-10 Finland
Multiple sclerosis
7425.5
278.1
229
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
203.1
174
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
188.6
163
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
180.8
157
*
L03AB07
ATC
interferon beta-1a; parenteral
+∞
109.4
99
*
H46
ICD-10 Finland
Optic neuritis
486.8
107.8
102
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
98.9
90
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
17.7
92.8
160
162
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
91.9
84
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
88.5
81
*
TAB00
NOMESCO Finland
Lumbar puncture
22.0
73.9
112
74
N86
ICPC
Multiple sclerosis
+∞
60.2
56
*
164
Kela drug reimbursment
Fingolimod
+∞
56.9
53
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
50.3
47
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
10.0
46.1
100
136
L04AX07
ATC
dimethyl fumarate; oral
+∞
45.9
43
*
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
45.9
43
*
L04AA31
ATC
teriflunomide; oral
+∞
43.7
41
*
L04AA27
ATC
fingolimod; oral
+∞
43.7
41
*
L03AB08
ATC
interferon beta-1b; parenteral
+∞
42.6
40
*
N04BB01
ATC
amantadine; oral
49.3
39.3
47
11
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
29.8
38.0
51
20
XA800
NOMESCO Finland
Neuropsychological investigation
13.0
32.0
58
53
XCK00
NOMESCO Finland
Perimetry
10.2
31.5
65
77
ZX120
NOMESCO Finland
Intravenous
7.3
30.6
79
135
2AB04
NOMESCO Finland
NA
169.9
30.2
31
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.1
29.5
108
285
R20.2
ICD-10 Finland
Paraesthesia of skin
7.2
28.6
74
126
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
28.3
28.2
38
15
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
23.0
27.2
39
19
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.5
27.0
76
145
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.9
24.2
45
43
M03BX01
ATC
baclofen; systemic
22.0
23.5
34
17
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
23.2
22
*
XKC03
NOMESCO Finland
Water cystometry
20.8
23.1
34
18
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
8.8
23.1
51
67
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.5
22.5
55
85
N03AX12
ATC
gabapentin; oral
4.1
20.5
89
268
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
20.0
19
*
H53.2
ICD-10 Finland
Diplopia
12.4
19.5
35
31
XKD06
NOMESCO Finland
Physiologic investigation of micturition
13.9
19.4
33
26
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
14.8
18.1
30
22
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
30.7
17.7
23
8
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
20.0
17.6
26
14
XCD10
NOMESCO Finland
Electrophysiological examination of eye
16.2
17.0
27
18
N06BA07
ATC
modafinil; oral
94.8
16.7
18
*
4AA23
NOMESCO Finland
NA
+∞
15.7
15
*
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
15.7
15
*
UKC02
NOMESCO Finland
Cystoscopy
4.0
14.9
63
181
H02AB04
ATC
methylprednisolone; systemic
3.5
14.9
79
272
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
11.2
14.5
27
26
G04BD09
ATC
trospium; oral
13.7
13.1
22
17
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
72.6
12.7
14
*
XKD00
NOMESCO Finland
Uroflowmetry
4.2
12.6
49
130
XKD03
NOMESCO Finland
Urethral pressure profilometry
12.3
12.5
22
19
N05CF01
ATC
zopiclone; oral
2.5
12.3
116
575
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
27.9
12.2
16
6
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
31.3
11.7
15
5
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
23.9
11.7
16
7
Z2445
NOMESCO Finland
Psychologist
5.7
11.5
33
63
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
11.5
11
*
G04BD08
ATC
solifenacin; oral
5.8
11.0
31
58
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
10.6
138
793
G36.1
ICD-10 Finland
Acute and subacute haemorrhagic leukoencephalitis [Hurst]
+∞
10.5
10
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
10.2
39
102
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
9.6
10.2
20
22
G04BD12
ATC
mirabegron; oral
3.9
9.5
39
109
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
+∞
9.4
9
*
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
9.4
9
*
R1250
NOMESCO Finland
Evaluation of functional capability
9.9
9.4
18
19
N06AX21
ATC
duloxetine; oral
2.9
9.2
57
219
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
8.9
90
452
L04AX01
ATC
azathioprine; systemic
4.7
8.8
29
66
N03AE01
ATC
clonazepam; systemic
3.7
8.8
38
112
WW400
NOMESCO Finland
Plasmaferesis
51.3
8.7
10
*
TKC22
NOMESCO Finland
Catheterisation instruction
10.4
8.6
16
16
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
92.2
8.5
9
*
L04AA40
ATC
cladribine; oral
+∞
8.4
8
*
A28
ICPC
Limited function/disability NOS
3.6
8.3
37
112
N99
ICPC
Neurological disease other
15.0
8.3
13
9
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
22.7
8.1
11
5
H57.1
ICD-10 Finland
Ocular pain
4.9
7.7
24
52
J01EA01
ATC
trimethoprim; systemic
2.1
7.6
95
524
N03AX16
ATC
pregabalin; oral
2.2
7.6
91
491
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.5
7.5
34
104
R35
ICD-10 Finland
Polyuria
4.2
7.4
27
69
H53.4
ICD-10 Finland
Visual field defects
9.7
7.4
14
15
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
16.2
7.3
11
7
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
7.2
35
114
A02BC02
ATC
pantoprazole; systemic
1.9
7.1
211
1589
N29
ICPC
Neurological sympt/complt other
10.3
7.1
13
13
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.2
7.1
36
121
H53.1
ICD-10 Finland
Subjective visual disturbances
3.8
7.0
28
78
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
6.9
92
515
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.8
6.9
44
172
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.1
6.8
20
41
L28
ICPC
Limited function/disability (L)
2.7
6.7
44
175
G04BD11
ATC
fesoterodine; oral
6.7
6.7
16
25
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.7
6.7
18
33
SPAT1216
SPAT
Assessment of functional ability
2.7
6.7
45
179
N04BC05
ATC
pramipexole; oral
4.0
6.4
24
63
AA1AD
NOMESCO Finland
CT of head and brain
2.2
6.4
70
359
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
8.4
6.4
13
16
N28
ICPC
Limited function/disability (N)
8.4
6.4
13
16
Z3226
NOMESCO Finland
Physiotherapist
2.2
6.4
68
346
R4150
NOMESCO Finland
Neuropsychological rehabilitation
9.5
6.3
12
13
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.2
6.3
31
102
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
+∞
6.3
6
*
L01BB04
ATC
cladribine; systemic
+∞
6.3
6
*
CS494
NOMESCO Finland
Other visual field testing
6.9
6.1
14
21
G04BD07
ATC
tolterodine; oral
4.7
6.1
19
42
Z3231
NOMESCO Finland
Registered nurse
2.0
6.0
91
535
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
81
46
22.06
102.86
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
79
45
21.86
100.10
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
58
23
29.54
84.53
1.2
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
121
236
7.03
63.66
4.5
2.6
g/l
9.9
10.0
0.14
115
217
(3011412) CD3 cells [#/volume] in Blood
48
26
20.96
61.40
5.0
2.3
e9/l
1.2
1.3
0.13
28
12
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
41
18
25.39
57.06
4.8
2.7
%
14.8
7.0
—
24
9
(4027681)
44
24
20.58
55.99
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
50
38
14.98
53.81
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
60
68
10.28
49.77
1.3
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
48
40
13.58
48.85
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
45
35
14.44
47.66
1.1
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
232
980
4.47
46.05
13.9
5.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
39
25
17.26
45.78
1.1
1.1
u/l
1.0
1.1
0.36
12
15
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
59
80
8.54
42.36
1.3
1.2
e6/l
8.5
7.6
0.07
51
64
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
59
80
8.54
42.36
1.4
1.3
e6/l
172.5
180.3
0.02
51
67
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
58
79
8.47
41.46
1.3
1.2
mmol/l
3.6
3.6
0.03
52
73
(3001604) Monocytes [#/volume] in Blood
294
1554
4.84
41.12
15.9
5.7
e9/l
0.6
0.5
1.37
276
1378
(3006315) Basophils [#/volume] in Blood
294
1561
4.80
40.69
16.0
5.7
e9/l
0.0
0.0
0.92
276
1381
(3022096) Basophils/100 leukocytes in Blood
277
1420
4.44
39.96
15.4
5.8
%
0.8
0.7
2.66
271
1324
(3002030) Lymphocytes/100 leukocytes in Blood
286
1523
4.47
38.51
15.3
5.8
%
27.5
29.3
1.92
279
1431
(3018010) Neutrophils/100 leukocytes in Blood
283
1506
4.37
37.89
15.2
5.6
%
58.1
56.7
1.18
278
1420
(3019198) Lymphocytes [#/volume] in Blood
294
1608
4.56
37.84
15.8
5.7
e9/l
1.7
2.0
1.36
280
1448
(3013115) Eosinophils [#/volume] in Blood
295
1621
4.57
37.62
16.1
6.1
e9/l
0.2
0.2
1.53
277
1456
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
19
17.66
37.03
5.7
2.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
59
97
7.01
35.55
1.7
1.6
iu/ml
44.1
0.0
—
8
16
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
29
12.77
33.85
4.5
1.7
e6/l
902.4
694.8
—
17
8
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
15
18.52
31.85
1.2
1.1
miu/ml
1608.1
1756.5
0.17
26
15
(3013650) Neutrophils [#/volume] in Blood by Automated count
295
1796
3.80
28.35
17.4
9.1
e9/l
3.7
4.0
1.88
281
1580
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
233
1267
3.14
26.27
2.8
2.2
nmol/l
91.3
74.3
10.56
223
1177
(3000850) Epithelial cells [#/volume] in Urine
131
553
3.08
22.50
4.3
2.2
e6/l
5.0
8.7
1.35
112
484
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
79
248
3.75
21.81
1.4
1.2
—
22.7
—
0
14
(3016018) Differential panel - Cerebral spinal fluid
24
26
9.78
20.18
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
35
8.22
19.79
1.3
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
160
802
2.71
19.44
5.9
2.5
e6/l
10.8
140.5
0.91
132
603
(3021879) Hepatitis B virus core Ab [Presence] in Serum
83
292
3.35
19.09
1.3
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
150
741
2.68
18.61
5.3
2.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
22
24
9.66
18.37
1.1
1.3
mmol/l
1.7
1.8
0.28
22
24
(3030467) Casts [#/volume] in Urine by Automated count
145
728
2.60
17.15
5.5
2.4
e6/l
0.1
0.4
1.87
117
534
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
24
9.20
16.93
7.0
2.9
%
45.2
46.7
—
9
6
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
25
37
7.16
16.33
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
296
2107
2.78
16.13
8.6
3.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
88
356
2.91
15.72
2.0
2.0
s
28.3
29.6
1.67
83
350
(3018095) Leukocytes [#/volume] in Urine
173
991
2.36
14.88
6.9
2.9
e6/l
14.5
77.9
2.08
139
665
(3026782) Osmolality of Urine
110
522
2.55
14.25
4.4
2.2
mosm/kgh2o
580.1
562.3
0.38
94
444
(3024561) Albumin [Mass/volume] in Serum or Plasma
183
1103
2.26
13.64
7.6
4.2
g/l
37.0
36.8
0.25
176
1039
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
8
23.52
13.01
3.8
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
101
479
2.51
12.97
1.7
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
138
754
2.30
12.87
3.9
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
16
9.72
12.62
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
7
25.32
12.57
2.7
3.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
26
7.22
11.96
1.4
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
89
420
2.46
11.42
4.7
2.2
e6/l
0.5
1.0
1.66
55
226
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
175
3.06
10.74
2.8
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
64
4.46
10.74
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
129
735
2.14
10.48
11.2
7.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
129
737
2.13
10.39
1.7
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
217
1519
1.99
9.78
8.0
4.2
estimate
0.0
0.0
0.50
44
293
(3035350) Ketones [Presence] in Urine by Test strip
216
1514
1.98
9.65
6.3
3.0
estimate
0.0
0.0
0.00
41
290
(3015736) pH of Urine
179
1178
1.98
9.59
4.9
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
80
390
2.33
9.41
5.1
2.3
e6/l
5.9
3.7
0.36
48
198
(3021589) Normoblasts [#/volume] in Blood
199
1381
1.92
8.90
17.4
8.3
e9/l
0.0
0.0
0.61
180
1139
(3009261) Glucose [Presence] in Urine by Test strip
216
1540
1.92
8.90
6.4
3.1
estimate
0.0
0.0
0.00
43
283
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
10
10.24
8.68
1.0
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
224
1632
1.90
8.47
5.6
4.0
mmol/l
6.5
6.4
0.12
210
1491
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
16
7.71
8.46
1.3
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
210
1504
1.88
8.33
8.0
5.6
umol/l
10.2
10.1
0.06
199
1428
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
14
8.06
8.03
1.2
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
8
15.43
7.76
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
8
15.43
7.76
1.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
53
235
2.46
7.64
7.0
4.2
%
0.2
0.5
1.07
13
50
(3017181) Myelocytes/100 leukocytes in Blood
55
253
2.37
7.31
7.3
4.3
%
0.6
0.9
0.38
17
70
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
287
2326
1.93
7.19
10.3
6.9
u/l
77.4
74.1
0.59
277
2194
(3004588) Protein electrophoresis panel - Serum or Plasma
34
125
2.89
7.07
1.9
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
108
655
1.90
6.95
5.5
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
142
947
1.79
6.71
6.3
6.3
inr
1.2
1.1
0.64
41
314
(3007164) IgA [Mass/volume] in Serum or Plasma
115
728
1.83
6.40
2.8
1.4
g/l
2.0
2.2
0.60
90
473
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
121
2.79
6.33
1.4
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
230
2.30
6.21
7.9
4.5
%
0.0
0.1
0.71
14
56
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
8
12.79
6.11
1.0
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
46
216
2.28
5.82
1.8
2.1
e9/l
4.0
4.2
0.26
35
182
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
9
11.37
5.82
1.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
87
529
1.83
5.43
1.7
1.6
pmol/l
113924500.1
26395284.2
0.35
79
466
(3021440) Promyelocytes/100 leukocytes in Blood
48
237
2.17
5.39
8.1
4.5
%
0.0
0.1
1.94
15
63
(3013707) Erythrocyte sedimentation rate by Westergren method
280
2337
1.74
5.36
4.4
3.8
mm/h
9.5
9.4
0.02
269
2202
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
172
1274
1.64
5.21
8.3
6.0
mmol/l
1.2
1.2
0.05
142
1087
(3019309) Folate [Moles/volume] in Red Blood Cells
67
382
1.91
5.09
1.6
1.6
nmol/l
1189.2
1241.6
0.19
56
297
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
9
10.20
5.05
1.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
281
2370
1.70
4.93
6.1
2.8
u/l
48.3
39.3
1.02
273
2279
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
126
2.50
4.86
2.1
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
388
1.88
4.85
1.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
74
458
1.76
4.30
3.2
3.1
ng/l
186.8
187.3
0.00
31
278
(46235355) HIV 1 and 2 tests - Meaningful Use set
128
924
1.58
4.10
2.0
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
164
2.18
4.06
1.2
1.3
miu/ml
146.5
250.0
1.57
11
87
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
7
10.16
4.02
3.1
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
24
4.25
3.91
1.1
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
143
1071
1.53
3.84
6.8
3.0
u/l
27.0
29.9
1.24
137
1018
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
5
12.16
3.77
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
234
1.94
3.74
2.5
2.2
u/l
356.8
3958.1
—
9
100
(3037522) Nuclear Ab [Titer] in Serum
78
512
1.66
3.64
1.7
1.4
titre
358.1
502.7
0.85
21
111
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
68
2.73
3.61
1.4
2.7
g/l
10.5
10.5
0.04
12
62
(3021960) Folate [Moles/volume] in Serum or Plasma
84
564
1.63
3.59
1.6
1.4
nmol/l
22.3
21.4
0.27
75
494
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
13
6.26
3.52
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
156
1209
1.49
3.49
7.3
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
58
2.84
3.46
3.8
3.7
e9/l
3.6
4.4
0.95
16
58
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
70
2.65
3.43
1.4
2.7
g/l
3.1
3.1
0.05
12
57
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
27
3.78
3.37
1.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
103
1376
0.66
3.29
2.3
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
351
3254
1.94
3.29
17.8
10.8
mg/l
18.3
19.5
0.26
272
2503
(3019150) Specific gravity of Urine by Refractometry
94
662
1.56
3.27
7.2
3.3
kg/l
1.0
1.0
0.64
12
79
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
60
2.74
3.27
3.8
3.9
%
59.1
56.6
0.34
16
60
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
51
308
1.76
3.22
3.5
3.6
%
31.8
31.9
0.03
44
215
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
255
1.82
3.18
2.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
127
961
1.48
3.14
3.4
3.1
ng/l
25.7
29.0
0.12
71
515
(3041096) Erythrocytes [Presence] in Urine by Automated
122
917
1.48
3.11
6.0
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
146
1137
1.46
3.11
7.4
5.2
mmol/l
1.2
1.2
0.46
135
1051
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
100
2.27
3.06
1.5
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
109
805
1.49
3.02
9.1
3.3
estimate
0.0
0.0
0.50
43
290
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
75
2.47
3.01
1.4
2.6
g/l
3.3
3.8
0.83
12
56
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
75
2.47
3.01
1.4
2.6
g/l
7.3
7.6
0.15
12
60
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
75
2.47
3.01
1.4
2.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
342
3166
1.75
2.93
17.6
11.1
mmol/l
3.9
3.9
0.12
336
3079
(40760892) CBC W Ordered Manual Differential panel - Blood
110
819
1.48
2.92
11.2
4.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
22
4.16
2.90
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
196
1.86
2.83
8.8
3.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
104
770
1.48
2.83
4.7
3.6
ph
7.4
7.4
0.44
24
142
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
104
2.18
2.80
1.3
1.1
—
—
—
0
0
(4062490)
10
31
3.29
2.79
2.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
293
3179
0.67
2.74
3.9
3.7
mmol/l
1.5
1.5
0.15
271
3001
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
126
980
1.43
2.63
2.2
1.8
pmol/l
100.4
98.8
0.14
64
513
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
93
685
1.47
2.58
2.5
2.0
mg/l
3.2
2.9
0.63
87
596
(3023511) Choriogonadotropin [Units/volume] in Urine
26
137
1.96
2.52
2.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
16
4.44
2.48
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
16
4.44
2.48
1.1
2.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
24
124
2.00
2.46
2.8
1.6
g/l
0.2
0.2
0.43
24
119
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
261
1.68
2.42
2.1
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
300
3224
0.68
2.40
4.1
4.0
mmol/l
2.9
2.9
0.04
278
3038
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
343
1.60
2.38
6.7
2.5
umol/l
4.6
6.9
1.09
43
297
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
296
3188
0.69
2.38
3.9
3.7
mmol/l
4.8
4.8
0.06
277
3028
(3000492) Spirometry study
17
335
0.48
2.30
1.1
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
40
249
1.68
2.30
2.9
4.3
u/l
218.7
234.2
0.61
40
242
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
128
1.93
2.27
5.9
2.5
e6/l
0.0
0.1
1.38
24
123
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
114
1.99
2.25
1.5
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
83
616
1.44
2.20
8.8
4.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
24
131
1.89
2.13
2.9
1.6
g/l
1.1
1.2
1.20
24
124
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
10
5.05
2.07
1.0
1.0
%
87.6
95.8
—
5
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
10
5.05
2.07
1.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
56
2.37
2.07
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
63
2.27
2.03
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
284
3061
0.72
2.03
3.6
3.3
mmol/l
1.2
1.2
0.01
263
2881
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
32
2.85
2.01
1.6
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
32
2.85
2.01
1.6
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
32
2.85
2.01
1.6
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
36
228
1.64
1.96
4.4
3.0
%
1.7
1.8
0.36
31
202
(3051651) Icteric interference index of Serum or Plasma
5
11
4.59
1.94
1.2
3.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.77
1.94
1.6
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.77
1.94
1.6
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.77
1.94
1.6
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
78
2.10
1.93
1.2
2.4
—
—
—
0
0
(3013512) EKG study
90
694
1.39
1.92
4.1
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
56
398
1.48
1.86
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
17
3.57
1.84
1.0
4.0
u/ml
802.3
604.6
—
6
17
(3015377) Calcium [Moles/volume] in Serum or Plasma
112
904
1.34
1.78
2.9
3.1
mmol/l
2.4
2.3
0.08
101
816
(3037121) Protein [Mass/volume] in Urine
16
81
2.02
1.77
4.3
4.1
g/l
0.4
0.2
—
7
39
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
36
2.54
1.75
1.3
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
1595
1.30
1.74
3.1
2.8
ug/l
106.5
78.8
1.09
175
1500
(3019230) Fractional oxyhemoglobin in Venous blood
8
30
2.70
1.73
2.5
1.6
%
73.0
61.3
—
8
30
(3004616) Nuclear Ab [Presence] in Serum
10
42
2.42
1.69
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
148
0.40
1.67
1.5
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
29
182
1.64
1.66
2.2
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
25
151
1.70
1.64
1.4
1.3
—
2.2
—
0
13
(3009871) Measles virus Ab [Titer] in Serum
5
14
3.60
1.62
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
106
1.83
1.62
1.7
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
112
918
1.31
1.59
2.7
2.3
u/l
53.3
55.7
0.39
106
861
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
20
3.03
1.58
4.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
19
108
1.80
1.53
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
410
0.63
1.50
1.9
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
34
228
1.54
1.50
3.1
3.5
pmol/l
4.5
4.6
0.41
27
203
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
28
2.53
1.46
1.4
3.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
110
1.77
1.45
9.3
7.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
40
2.28
1.41
2.4
4.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
404
1.39
1.39
2.7
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
9
41
2.22
1.38
1.3
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
23
2.63
1.37
2.0
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
17
2.97
1.36
6.8
10.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
47
2.16
1.35
2.8
3.9
—
5348.0
—
0
5
(3019060) Gas panel - Arterial blood
21
129
1.66
1.33
7.2
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
45
329
1.42
1.32
3.3
2.2
%
20.8
24.3
0.85
35
282
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
55
2.03
1.28
2.5
4.1
—
1.2
—
0
6
(1616796) Gas panel - Central venous blood
9
44
2.07
1.27
2.7
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
123
1.66
1.26
2.1
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
317
3004
1.32
1.25
5.6
4.8
mu/l
1.7
1.8
0.63
303
2828
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
71
1.86
1.21
2.6
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
71
1.86
1.21
1.0
1.3
—
1.2
—
0
6
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
39
2.07
1.16
1.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
316
0.65
1.15
1.3
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
30
2.36
1.13
1.3
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
33
236
1.44
1.11
3.5
2.3
g/l
0.2
0.2
0.19
33
224
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
31
2.28
1.11
2.1
1.9
—
—
—
0
0
(3012544) pH of Venous blood
27
187
1.48
1.07
10.9
3.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
22
322
0.66
1.07
1.3
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
90
1.69
1.05
2.0
2.3
g/l
1.4
1.3
0.07
15
81
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
274
2571
1.23
1.05
4.5
4.2
pmol/l
14.5
14.4
0.54
254
2424
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
189
0.57
1.04
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
189
0.57
1.04
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
189
0.57
1.04
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
189
0.57
1.04
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
135
0.51
1.00
15.6
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
61
1.83
0.99
2.0
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
41
312
1.35
0.98
2.8
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
116
1.58
0.98
2.5
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
108
1.60
0.98
1.2
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
173
0.57
0.97
2.7
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
80
668
1.25
0.97
5.7
3.8
mg/mmol
9.7
10.5
0.06
48
417
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
50
1.82
0.97
4.4
2.9
mmol/l
25.7
24.1
—
9
45
(40761511) CBC panel - Blood by Automated count
355
3447
1.41
0.96
18.2
10.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
101
1.61
0.95
6.1
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
85
717
1.24
0.94
2.5
2.5
umol/l
302.8
7657.7
3.61
78
643
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
27
2.24
0.94
5.2
1.6
promille
1.2
1.4
—
6
21
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
52
1.75
0.93
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
52
1.75
0.93
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
104
0.47
0.90
1.2
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
156
0.57
0.90
1.2
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
156
0.57
0.90
1.2
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
264
1.36
0.90
4.0
2.1
u/l
32.5
32.6
0.01
28
231
(3002032) Base excess in Venous blood by calculation
26
186
1.43
0.90
11.2
3.2
mmol/l
2.2
1.9
0.23
18
148
(3039443) Prostate specific Ag panel - Serum or Plasma
8
43
1.88
0.88
1.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
32
239
1.37
0.87
7.7
4.3
—
—
—
0
0
(4034850)
6
112
0.53
0.84
7.5
8.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
313
3003
1.23
0.83
15.4
9.5
ml/min/173m2
93.8
90.2
2.30
268
2444
(3045424) Erythrocytes [Presence] in Urine
8
47
1.72
0.81
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
46
368
1.28
0.80
3.3
3.9
%
20.4
22.4
0.28
19
137
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
33
1.83
0.79
1.2
1.8
—
—
—
0
0
(44813793)
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
25
0.00
0.79
0.0
2.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
125
0.55
0.79
1.3
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
43
343
1.29
0.77
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
132
1.46
0.77
1.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
31
237
1.34
0.75
6.7
7.2
mmol/l
1.3
1.2
0.02
21
184
(21494755) Public health laboratory ask at order entry panel
42
519
0.79
0.74
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
717
1.20
0.74
1.8
1.8
mg/l
0.6
0.8
1.49
58
540
(3024928) Oxygen saturation in Venous blood
7
38
1.86
0.74
3.6
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.6
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(4281824)
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
56
1.62
0.73
2.4
2.0
kpa
4.9
4.9
—
9
56
(3027315) Oxygen [Partial pressure] in Blood
9
56
1.62
0.73
2.4
2.0
kpa
9.7
9.2
—
9
56
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.1
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
74
634
1.21
0.72
5.3
3.1
mg/l
1952.8
283.5
0.66
48
412
(3044889) 12 lead EKG panel
216
2021
1.16
0.72
3.5
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
64
541
1.22
0.71
2.7
3.1
ng/l
909.7
676.6
0.18
57
444
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
61
1.66
0.69
2.6
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
27
1.86
0.68
2.2
1.7
mmol/l
5.6
5.6
—
5
19
(1002224) Polysomnography panel
13
189
0.68
0.65
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
44
1.60
0.65
1.9
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
24
181
1.35
0.65
13.1
7.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
290
0.74
0.64
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
71
1.57
0.62
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
30
1.68
0.61
1.6
1.1
—
1.1
—
0
12
(3022621) pH of Urine by Test strip
23
174
1.34
0.61
5.1
2.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
23
174
1.34
0.61
6.7
3.3
ng/l
89.2
71.0
0.37
23
160
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
51
1.58
0.61
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
76
666
1.18
0.59
1.3
1.3
iu/ml
13.9
29.0
2.50
19
215
(3003694) ABO and Rh group [Type] in Blood
90
1007
0.86
0.59
1.6
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
69
787
0.85
0.57
1.5
1.6
mmol/l
1.4
1.4
0.03
59
692
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
221
1.29
0.57
1.1
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
11
73
1.52
0.57
1.1
1.1
—
10.4
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
158
0.69
0.54
1.2
1.4
—
—
—
0
0
(3010421) pH of Blood
9
63
1.44
0.52
2.6
2.2
ph
7.4
7.4
—
9
56
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
100
1.42
0.52
2.1
2.2
%
102.6
96.5
0.69
14
94
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
40
1.51
0.52
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
127
1.35
0.50
2.2
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
15
200
0.74
0.49
1.6
1.5
mu/l
291.9
310.0
0.12
15
179
(4268621)
7
46
1.53
0.48
1.9
2.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
177
0.73
0.48
1.9
2.1
mg/l
4.7
2.3
—
8
120
(3016879) Cocaine [Presence] in Urine
14
187
0.74
0.46
8.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
50
1.41
0.45
2.3
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
286
1.21
0.43
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
31
1.62
0.43
4.6
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1446
1.11
0.43
4.5
3.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
195
0.76
0.42
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
58
1.39
0.41
1.6
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
60
1.34
0.40
1.4
1.3
—
—
—
0
0
(4306422)
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
101
0.69
0.40
1.0
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
76
689
1.13
0.39
2.7
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
159
0.75
0.39
9.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
66
1.37
0.38
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
37
319
1.18
0.37
1.7
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
33
383
0.85
0.36
1.5
1.2
—
—
—
0
0
(3036489) Thrombin time
15
117
1.29
0.35
2.1
2.2
s
20.6
21.2
—
10
99
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
43
1.40
0.35
1.3
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
426
1.14
0.34
1.8
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
199
0.80
0.34
7.4
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
89
823
1.11
0.33
1.3
1.2
u/ml
0.7
1.9
1.57
19
245
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
6
89
0.67
0.33
1.3
1.1
—
1.8
—
0
29
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
73
668
1.11
0.33
1.9
2.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
90
0.66
0.33
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
90
0.66
0.33
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
198
0.80
0.33
7.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
198
0.80
0.33
7.4
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
197
0.80
0.32
7.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
52
1.35
0.31
2.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
53
1.33
0.31
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
55
1.28
0.30
1.0
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
71
653
1.11
0.30
1.4
1.3
u/ml
4.3
10.8
1.00
26
276
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
251
1.17
0.29
3.3
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
531
0.89
0.28
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
82
762
1.10
0.28
5.4
2.9
mmol/l
7.5
8.0
0.45
69
658
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
63
1.28
0.28
1.6
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
64
1.26
0.27
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
66
1.22
0.27
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
225
1.17
0.26
1.9
2.1
u/ml
34.1
42.7
0.16
26
213
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
301
1.14
0.26
1.4
1.2
iu/ml
210.6
178.3
0.10
14
130
(4094501)
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
74
0.67
0.26
1.0
1.0
—
0.6
—
0
29
(3028707) Methadone [Presence] in Urine by Screen method
6
82
0.73
0.24
6.3
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
285
1.13
0.23
2.4
2.7
ug/l
0.7
0.7
0.01
21
157
(44790048)
5
38
1.32
0.23
1.6
1.5
—
—
—
0
0
(44806118)
5
38
1.32
0.23
1.6
1.5
—
—
—
0
0
(44790049)
5
38
1.32
0.23
1.6
1.5
—
—
—
0
0
(44790047)
5
38
1.32
0.23
1.6
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
39
1.29
0.23
1.2
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
201
1.15
0.21
6.9
6.1
mmol/l
1.4
1.2
0.36
23
192
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
98
930
1.07
0.21
3.0
2.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
0.5
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.9
—
112.8
—
0
13
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
221
1.14
0.20
2.2
2.3
ml/min/173m2
73.7
78.9
—
7
91
(3042936) Bacteria identified in Isolate by Culture
41
375
1.10
0.20
2.8
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
272
2768
0.94
0.19
5.1
4.5
mmol/mol
38.3
38.4
0.09
261
2637
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
194
1.14
0.19
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
300
1.11
0.18
9.1
5.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
61
1.15
0.17
1.9
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
8
68
1.18
0.16
1.5
3.9
mmol/l
3.7
3.8
—
8
62
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
68
1.18
0.16
1.1
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
214
0.88
0.16
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
178
1.13
0.15
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
78
1.16
0.15
1.9
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
80
1.13
0.15
1.9
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
318
3146
1.06
0.14
21.9
11.4
%
40.0
40.4
0.43
245
2578
(3048689) Calprotectin [Mass/mass] in Stool
45
479
0.93
0.14
2.0
2.3
ug/g
86.1
94.4
0.13
38
379
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
89
855
1.05
0.14
1.7
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
97
0.82
0.14
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
20
221
0.90
0.13
1.2
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
613
1.05
0.11
1.8
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
134
1.12
0.11
5.2
5.0
mmol/l
24.3
24.6
0.21
15
134
(4035726)
25
231
1.09
0.11
2.1
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
823
1.04
0.10
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
155
1.10
0.09
1.6
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
113
0.88
0.08
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
33
348
0.94
0.08
1.5
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
117
1.12
0.08
1.0
1.1
—
5.5
—
0
21
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
64
1.10
0.08
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
66
1.06
0.08
1.9
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
82
0.85
0.07
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
9
86
1.05
0.07
10.2
4.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
132
0.91
0.06
1.8
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
104
0.86
0.06
1.6
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
104
0.86
0.06
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
105
0.85
0.06
1.6
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
111
0.90
0.06
2.2
2.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
26
250
1.04
0.03
18.5
17.0
inr
1.3
1.2
—
7
35
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
303
3018
1.02
0.03
4.0
3.6
mmol/l
5.8
5.7
0.28
284
2821
(3008898) HLA-B27 [Presence]
21
202
1.04
0.02
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
222
1.04
0.02
1.7
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
262
2630
0.99
0.02
3.4
3.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
133
1339
0.99
0.01
2.5
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
562
1.02
0.01
1.4
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
20
206
0.97
0.00
1.1
1.1
—
106.0
—
0
5
(40761536) Microorganisms panel - Urine sediment
26
258
1.01
0.00
11.3
3.0
—
—
—
0
0
(4010399)
20
195
1.03
0.00
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
224
0.98
0.00
1.6
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
95
0.95
0.00
1.3
1.5
u/l
20.0
22.9
—
9
77
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
9.2
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
72.0
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
48.1
—
0
8
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
81
0.99
0.00
1.4
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
70
1.00
0.00
1.1
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
4.7
3.3
mg/l
1.3
1.4
—
7
65
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
4.0
—
101.1
—
0
8
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
66
0.91
0.00
4.5
2.7
umol/l
5.5
5.4
—
6
49
Mortality – FinRegistry
↥Association
Association between endpoint G6_DISSOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DISSOTH | 2.024 [1.58, 2.6] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.361 |
During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 1346 females with G6_DISSOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DISSOTH | 2.036 [1.57, 2.63] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 622 males with G6_DISSOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_DISSOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.179% | 0.402% |
| 5 | 1.097% | 2.427% |
| 10 | 3.192% | 6.325% |
| 15 | 6.203% | 11.838% |
| 20 | 10.507% | 19.86% |
Relationships between endpoints
↥Index endpoint: G6_DISSOTH – Other acute disseminated demyelination
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data